Open AccessNeo-Adjuvant Chemotherapy in Luminal, Node Positive Breast Cancer: Characteristics, Treatment and Oncological Outcomes: A Single Center’s Experience
Author(s) -
Erika Barbieri,
Damiano Gentile,
Alberto Bottini,
Andrea Sagona,
Wolfgang Gatzemeier,
Agnese Losurdo,
Bethania Fernandes,
Corrado Tinterri
Publication year - 2021
Publication title -
meme sağlığı dergisi/meme sağlığı dergisi
Language(s) - English
Resource type - Journals
eISSN - 1306-0953
pISSN - 1306-0945
DOI - 10.4274/ejbh.galenos.2021.2021-4-8
Subject(s) - medicine , breast cancer , sentinel lymph node , axillary lymph node dissection , mastectomy , sentinel node , single center , odds ratio , axilla , chemotherapy , confidence interval , biopsy , lymph node , breast surgery , oncology , surgery , cancer
Neo-adjuvant chemotherapy (NAC) is the treatment of choice for patients with locally advanced breast cancer (BC). In luminal-like BC, the decision to administer NAC remains controversial. The purpose of this study was to describe the clinical characteristics, treatment, and oncological outcomes of luminal-like, node positive, BC patients treated with NAC, and to identify independent predictive factors for treatment.